Recent advances in understanding myelofibrosis and essential thrombocythemia
about
The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin.Unifying mechanism for different fibrotic diseases.Primary myelofibrosis and its targeted therapy.Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis.The role of the extracellular matrix in primary myelofibrosis.Crucial factors of the inflammatory microenvironment (IL-1β/TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study.Low-dose methotrexate in myeloproliferative neoplasm models.JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.ASXL1 mutations in Chinese patients with essential thrombocythemia.[The identity of normal and cancer stem cells].Multiple Roles of Glycans in Hematological Malignancies
P2860
Q33440994-05614A7D-762F-4E36-8803-E192EFAEE18CQ38829704-24945A1C-A8BD-496C-BCB7-339F1F2ACCE6Q38931426-6EEDC550-B40B-41F5-B021-798653C42BA9Q39069010-0BEADEA7-A14D-4FA7-90A8-39351175746AQ39117766-70B7CCA2-4D90-47A4-9F74-8D6F5A293A13Q39986585-1876310C-F5DE-41A3-8DF6-D07DAA9CEF3EQ47135834-9B0F6168-4C7A-4713-AC38-163EB6A9C956Q48109284-31D53028-4FDE-409F-A65F-BD2C8FA18F20Q50201003-FAF3B60D-F11D-4FB6-AF01-FA72AA7A6AA4Q54112495-5C43819A-E1C8-489D-BDE6-49D42D7B8250Q54435302-C82D2631-6B94-4F64-97A1-DB9A9F83389CQ58761454-5ED5C72F-6020-49B5-A616-2A6F3B342B0F
P2860
Recent advances in understanding myelofibrosis and essential thrombocythemia
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Recent advances in understanding myelofibrosis and essential thrombocythemia
@ast
Recent advances in understanding myelofibrosis and essential thrombocythemia
@en
Recent advances in understanding myelofibrosis and essential thrombocythemia
@nl
type
label
Recent advances in understanding myelofibrosis and essential thrombocythemia
@ast
Recent advances in understanding myelofibrosis and essential thrombocythemia
@en
Recent advances in understanding myelofibrosis and essential thrombocythemia
@nl
prefLabel
Recent advances in understanding myelofibrosis and essential thrombocythemia
@ast
Recent advances in understanding myelofibrosis and essential thrombocythemia
@en
Recent advances in understanding myelofibrosis and essential thrombocythemia
@nl
P2860
P50
P3181
P1433
P1476
Recent advances in understanding myelofibrosis and essential thrombocythemia
@en
P2860
P3181
P356
10.12688/F1000RESEARCH.8081.1
P407
P577
2016-01-01T00:00:00Z